Thus, our data indicate that Gdpd3 is a key suppressor of the AKT/mTORC1 pathway in CML stem cells, repressing their proliferation despite their expression of the BCR-ABL1 oncogene. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.